Related Experiment Video
Updated: Mar 9, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Implementation of a β-Agonist/Airway Clearance Protocol in a Pediatric ICU
Gary R Lowe1, J Randy Willis2, Shasha Bai3
1Respiratory Care Services, Arkansas Children's Hospital, Little Rock, Arkansas. lowegr@archildrens.org.
Insights
Respiratory therapist-driven protocols for beta-agonist and airway clearance interventions significantly reduced length of stay and ventilator days in pediatric intensive care units. The protocol was positively received by staff, enhancing the perceived value of respiratory therapists.
Area of Science:
- Pediatric Critical Care Medicine
- Respiratory Therapy Protocols
- Evidence-Based Practice
Background:
- Established respiratory therapist (RT)-driven protocols aim to reduce unnecessary therapy, costs, and hospital stays.
- This study evaluated an original RT-driven protocol for beta-agonist and airway clearance interventions in a pediatric ICU lacking such a system.
Discussion:
- Survey results indicated positive perceptions and increased perceived value of RTs following protocol implementation.
- No significant differences in patient demographics or severity of illness were observed between pre- and post-intervention groups.
Key Insights:
- RT-driven protocols led to statistically and clinically significant reductions in length of stay, beta-agonist therapies, airway clearance therapies, and ventilator days.
- The protocol demonstrated effectiveness in improving patient outcomes within the pediatric intensive care setting.
Outlook:
- Further research can explore broader implementation of RT-driven protocols in pediatric ICUs.
- This study provides valuable data on the impact of specific protocols where clinical evidence is limited.
Background:
Respiratory therapist (RT)-driven protocols have been in use for over 30 years. Protocols have been reported to decrease unnecessary or harmful therapy, health-care costs, and hospital stay. This study represents the evaluation of an original respiratory care protocol in the pediatric ICU at Arkansas Children's Hospital for β-agonist and airway clearance interventions where one did not exist.
Methods:
This project was composed of 2 parts: a survey administered to RTs and licensed independent practitioners and a retrospective review of outcome data comparing a therapist-driven β-agonist/airway clearance protocol with physician-directed respiratory care ordering in a patient population admitted for acute respiratory failure.
Results:
Acceptance of the protocol was evident in the survey responses because overall perceptions surrounding the implementation of the β-agonist/airway clearance protocol were positive, and responders perceived that the protocol implementation elevated the status and increased the value of respiratory therapists. For the comparison of physician-directed orders with therapist-driven protocols, there were no significant differences between pre- and post-intervention groups for mean age, sex, mean daily acuity, or mean weighted daily acuity (P = .33, .19, >.99, and .79, respectively). There were also no differences in pediatric index of mortality 2, pediatric index of mortality 2 rate of mortality, pediatric risk of mortality 3 probability of death, and pediatric risk of mortality 3 scores (P = .63, .56, .19, and .44, respectively) between the 2 groups. When comparing physician-directed orders to therapist-driven protocols, all outcome measures (length of stay, β-agonist therapies, airway clearance therapies, and ventilator days) showed statistically and clinically important reductions, adjusting for subject characteristics (P < .001) for the therapist-driven protocol group.
Conclusions:
In this institution, implementation of a β-agonist/airway clearance protocol resulted in significant reductions of subject interventions and improved outcomes by decreasing length of stay and ventilator days as well as contributing information where clinical evidence is scant, specifically the pediatric ICU.
Related Concept Videos
Cardiopulmonary Resuscitation II: ACLS Airway Management
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Asthma-IV: Nursing Management
First, in...
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-IV

